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1. Introduction 
Photopolymerization techniques provide a number of economic advantages over the usual 
thermal techniques. These include: rapid cure reaction, low energy requirements, use of 
room temperature and solvent free formulations as well as low cost. Light beams are used to 
start the photochemical reactions in organic materials (monomers, oligomers, polymers) to 
form a new polymeric system This technique allows us to prepare materials with several 
applications in industry (UV curable inks, printing plates and adhesives, among others). 
Photopolymerization has also been used in electronic materials, optical materials, 
membranes, coatings and surface modifications. The efficiency of the polymerization 
reaction is dependent on the monomers, the photoinitiator and the beam wavelength. 
More recently, this technique has been used in the preparation of biomaterials with 
applications in important areas as tissue engineering, (Nguyen & West, 2002), biosensors, 
(Alves et al., 2009), development of drug delivery systems (Rydhholm et al., 2007) dental 
restorations in situ (Gatti et al. 2007)) and surface modifications to control the materials cell 
adhesion (Alves et al., 2011). Photopolymerizable polymers have found numerous 
applications in the field of tissue engineering for the engineering of tissues as bone, cartilage 
and liver (Ifkovits & Burdick, 2007) as they may be photopolymerized in vivo and in vitro. 
Here we will report some of the literature scientific reports in this field. 
Ortega and co-workers (2008) showed that the photopolymerization kinetics as well as the 
resulting structure of the methacrylate based structures are influenced by the monomers 
and oligomers properties, the reaction conditions, e.g. light intensity, reaction temperature 
and type of photoinitiator. 
Gatti et al. (2007) referred that photopolymers have been widely used in several dentistry 
applications. Different monomers have been used for this purpose. Gatti et al. (2007) 
prepared and characterized copolymers obtained from bisphenylglycidyl dimethacrylate, 
triethylene glycol dimethacrylate and urethane dimethacrylate.  These copolymers were 
used to obtain dentistry resins. The kinetic parameters of the reaction were evaluated by 
using photocalorimetry 
As it is well known, hydrogels are three-dimensional, hydrophilic, polymeric networks 
capable of imbibing large amounts of water or biological fluids. They represent an 
important class of materials to be applied in biotechnology and medicine. These networks 
have been used as membranes for separating solutes, wound dressings, delivery systems for 
gene therapy and protein controlled-released systems. Hydrogels have also been applied as 
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bioadhesives, for immobilization of enzymes and cells and in tissue engineering. These 
photocrosslinked polymers can be obtained either from natural polymers (eg. hyaluronic 
acid) or from synthetic monomers in the presence of a photoinitiator, using visible or 
ultraviolet light (Nguyen & West, 2002). 
Tai et al. (2009) prepared and characterized photocrosslinked hydrogels from synthetic 
monomers to be used as advanced injectable biomaterials. They observed that the 
PEGMEMA-PPGMA-EGDMA copolymers, with both thermoresponsive and 
photocrosslinkable properties, have excellent mechanical properties above the LCST. They 
suggested that the biodegradability of these gels could be increased by copolymerization 
with biodegradable blocks. 
Other authors (Seiffert et al., 2007) prepared hydrogels by crosslinking a dimethylmaleimide 
functionalized polyacrylamide. They observed that this method could give a very efficient 
method to synthesize hydrogels in a selective and controlled manner. 
Tae II Son group developed a visible light-crosslinkable porcine gelatine containing furfuryl 
groups by using Rose Bengal (4,5,6,7-tetrachloro-2',4',5',7'-tetraiodofluorescein) as a visible 
light sensitizer. These authors referred that the material could be used in the dental field as 
well as a visible light induced crossslinkable bioselant. 
Schuster and co-workers (2009) developed gelatine based photopolymers for bone 
replacement materials. For this purpose, as a first step, they prepared different methacrylate 
based gelatine derivatives by reaction of this polymer with glycidylmethacrylate and other 
acrylate monomers. In this way, they obtained polymerizable gelatin that was polymerized 
with a polyethyleneglycol monomethacrylate comonomer. They where then, able to prepare 
cellular structures by using stereolithography. 
Nichol and colleagues (2010) prepared a photopolymerizable gelatine methacrylate for 
tissue engineering applications. They modified gelatine with methacrylic anhydride, which 
was subsequently photopolymerized with UV irradiation, in the presence of Irgacure 2959. 
These authors suggested that these hydrogels could be applied in microscale applications to 
create endothelial-lined vessels within engineered tissues. 
Hu and co-workers (2010) used a carboxymethylated chitosan modified with 4-
nitrocinnamate acid to obtain a photopolymerizable derivative without initiator. They were 
able to prepare a gel with good mechanical properties that was efficiently used as a matrix 
in a drug delivery system. 
Although the extension of described works, the photopolymerization/photocrosslinkage are 
processes which are still being studied and therefore explored by many researchers. In this 
chapter, we wish to report some of the highlights of our work, in this field, still on course in 
our research group. 
2. Photoinitiators 
The photocrosslinking technology by using ultraviolet (UV) or visible light has been used 
extensively in several applications including several types of coatings and biomedical 
applications. When this technology is used in combination with biodegradable polymers 
very interesting solutions can be found for drug delivery and tissue engineering 
applications. The photoinitiators are one of most important compounds used in the 
formulation due to its influence on different reaction parameters. The chemical nature of the 
photoinitiator determines the reaction rate, the spectral sensitivity (wavelength of 
absorption), the light resistance and the stability of the materials under storage conditions. 
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In order to obtain crosslinked polymers, it is necessary to generate free radicals in the 
system that will induce a free radical chain polymerization of monomers and oligomers. 
Both have reactive functional groups that can be activated under the presence of reactive 
radicals, resulting in the formation of crosslinked structures (Corrales et al., 2003). In the 
mechanism involved in the process we can consider three main reactions: initiation, 
propagation and termination. Photoinitiators have an essential role in this process, since 
they are excited under UV radiation leading to the formation of the active radicals that start 
the polymerization mechanism (initiation). The crosslinking can occur by the reaction of the 
functional groups that exist in the monomer or polymer structure, which results in a direct 
intermolecular crosslinking (Figure 1).  
 
 
Fig. 1. Representation of the photopolymerization/photocrosslinking processes (Adapted 
from Decker, 2002). 
The crosslinking density plays a critical role in the performance of the biomaterial since it 
controls properties including permeability, degradation, thermal and mechanic and water 
uptake (Martens et al., 2003). The use of the proper photoinitiator allows the fine tuning of 
the reaction rate and therefore the control of the density of crosslinking. 
We can consider the existence of two basic types of photoinitiators (Allen et al., 1999): Type 
I, and Type II. Type I photoinitiators when exposed to UV radiation suffer a fragmentation 
process that origins the formation of the active radicals with the capacity to start the radical 
polymerization. Examples of such compounds are the acetophenone derivatives and the α-
hidroxyalkyl phenones. The α- hydroxyalkylphenones, as for example 4-(2-
hydroxyethylethoxy)-phenyl–(2-hydroxy-2-methyl propyl) ketone (Irgacure® 2959, Ciba) are 
extremely reactive and present a high thermal stability. Once irradiated, benzoyl and alkyl 
radicals are formed and although both radicals are reactive to initiate the polymerization, 
the benzoyl presents higher reactivity. 
Type II photoinitators require the presence of molecules, in the system, that suffer a primary 
process of hydrogen abstraction. These molecules are often referred as co-initiators and are 
usually tertiary amines. The reaction starts with the formation of the intermediary species 
resulting from the interaction between the amine and the photoinitiator carbonyl group. The 
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process continues with an electron and a hydrogen transfer resulting in the radical 
formation. 
When biomedical applications are concerned, the biocompatibility of the photoinitiator is a 
critical issue to be considered. Williams and co-authors have studied the biocompatibility of 
the three different photoinitiators (2-hidroxy-1-[4-(2-hidroxyethoxy)phenyl]-2-methyl-1-
propanone (Irgacure® 2959); 1-hidroxycyclohexyl-1-phenyl ketone (Irgacure® 184) and 2,2-
dimethoxy-2-phenylacetophenone (Irgacure® 651)) commonly used in the preparation of 
biomaterials using six cellular lines (Williams et al., 2005). Their results revealed that 
different cell types react differently to the same concentrations of the same photoinitiator. 
Among the three compounds tested, Irgacure® 2959 presented the better results since very 
high cell tolerance (in all cell lines) was observed for a broad range of photoinitiator 
concentrations.  
3. Biomedical applications 
The UV irradiation is frequently used in the area of biomaterials as a strategy to modify both 
surface and bulk properties of polymers. These modifications allow us to improve some of 
their assets such as hemo and biocompatibility. It is also possible, by using radiation, to 
prepare crosslinked systems that may be used to encapsulate cells (Cruise et al., 1999; Hill et 
al., 1997; Li et al., 2006), proteins (Leach et al., 2005) or other compounds to be controlled 
delivered (Vieira et al., 2008; Tripodo et al., 2005). 
In the following sections a literature review in some of the possible applications of 
photocrosslikable polymers will be presented. Also, some examples of some of the work that 
has been done in our own research group will be given. 
3.1 Bioadhesives 
Primary wound healing of a plan-to-plan oriented scar formation is usually accomplished 
by hand sewing or stapling the corresponding layers of each side of the incision (Sheikh et 
al., 2000). However, both methods have been associated to wound infection and granule 
formation due to their degradation in the organism. They also present other disadvantages, 
such as the need to be removed, in most cases and the pain associated with their use. 
Topical skin adhesives are increasingly being used by health professionals to replace 
sutures, staples and adhesive strips for wound closure. The use of adhesives provides 
several advantages that include: rapid application, unnecessary administration of 
anesthetics, no trauma is induced to tissues, less pain, unnecessary sutures or staples 
removal and improved cosmetic results. 
Tissue adhesives may also be used as delivery systems and can be engineered for slow, 
localized release of bioactive molecules (Spicer & Mikos, 2010), such as pain treatment drugs 
or antibiotics (Fujimoto et al., 1997). They can be used as vehicles to growth factors (Catelas 
et al., 2008), and cell lines to assist on healing, namely, in poorly healing tissues like cartilage 
(Hoemann et al., 2005). Very recently, Spicer & Mikos (2010) reported several studies 
concerning the entrapment of drugs and growth factor in fibrin gels. Entrapment of such 
bioactive compounds was achieved by simply mixing the components before crosslink of 
the fibrinogen. At the end of the process a fibrin gel containing a bioactive molecule was 
obtained (Figure 2). The authors concluded that controlled delivery of drugs or factors by 
this method was in fact possible, and that release kinetics could be tailored through 
composition, affinity and covalent linkage between the bioactive molecules and fibrin. 
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Fig. 2. Fibrin gel preparation and drug/growth factor entrapment. (Adapted from Spicer 
and Mikos, 2010). 
Regardless their nature, surgical adhesives must obey some clinical requirements. They 
must hold the two sides of the tissue together, until it is no longer necessary, and then they 
should be degraded to biocompatible products (Lipatova, 1986). Also, an adhesive would 
ideally present the ability to cure in a moist environment.  
Among the adhesives available on the market, the most applied are the ones based either 
on fibrin (Silver et al., 1995; Dunn & Goa, 1999) or cyanoacrylates (Leahey et al., 1993; 
King & Kinney, 1999). Both classes present some advantages as well as some 
disadvantages. Although fibrin glues contribute efficiently to hemorrhage control at 
bleeding wounds, their application is limited by their possible immunogenicity and risk 
of blood transmission diseases such as HIV and BSE. On the other hand, cyanoacrylates 
present a fast curing rate and a very strong adhesion to tissues but have been reported to 
degrade in aqueous media to produce formaldehyde, which causes inflammation and has 
got carcinogenicity potential. 
Considering the described limitations, other options are now being considered, and 
among synthetic materials, urethane-based adhesives have been considered to be quite 
promising for this application. However, although several studies have already been 
conducted by other authors (Lipatova, 1986; Sheikh et al., 2000) and also by our research 
group in trying to develop urethane pre-polymers to be applied as bioadhesives (Ferreira 
et al., 2007, 2008a), these have proved that despite the good adhesion results, the curing 
time is too long to face surgical demands. UV curable adhesives offer major advantages 
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compared to pre-polymers systems, such as fast-curing rate, control of the polymerization 
heat evolution and are ideal for application to weakened and diseased tissue (Benson, 
2002). 
The photopolymerization and photocrosslinkage of polymers intending the preparation of 
bioadhesives has been largely developed during the second half of the 20th century. 
Throughout this period, several works translated into patents and scientific papers were 
published focusing on the development of various aspects of photopolymerization. Among 
them, new UV radiation sources, functionalized monomers and oligomers as well as new 
technologies for preparation of particles stand out (Moon et al., 2005). 
A biological adhesive must present a combination of biocompatibility, performance and 
effectiveness. It should also present a fast curing rate when in contact with the living tissues. 
UV curable adhesives offer major advantages, such as fast-curing rate, control of the 
polymerization heat evolution, superior control over the final properties of the material and 
are ideal for application to weakened and diseased tissue (Benson, 2002). Another great 
advantage of such UV sensitive systems is allowing the adhesive to cure almost 
instantaneously, however selectively, in strongly illuminated areas such as the operating 
rooms (Decker, 2002). 
Kao et al. (1997) have synthesized UV irradiation curable bioadhesives based on N-
vinylpyrrolidone. The obtained results showed that these adhesives presented suitable 
adhesive strength. However, the UV induced setting time was of approximately 3 min 
which is a value that should be improved when surgical applications are concerned. A 
few years later, Ono and co-workers developed another photocrosslinkable adhesive 
based on chitosan. Its UV sensitivity and consequent crosslinking was dependent on azide 
groups that were introduced to the chitosan molecules. In vivo tests were conducted to 
evaluate its efficacy as well as the organism response (Ono et al., 2001). The final results 
showed that, 30 days after the surgical procedure, the adhesive was still present at 
implantation site surrounded by fibrous tissue. Also, inflammatory cells were observed 
around the material. 
Since then, some work has been published describing attempts to develop a bioadhesive 
based on photosensitive polymers (Ho & Young, 2006; Grinstaff, 2007; Brigham et al., 2009). 
As an example, in our research group, Ferreira and co-workers (2008b) developed a 
photocrosslinkable biodegradable bioadhesive based on polycaprolactone (PCL). PCL is a 
semi-crystalline linear biodegradable aliphatic polyester that has been used in several 
medical applications already approved by the US Food and Drug Administration. Its 
structure presents several aliphatic ester linkages (Figure 3) that can undergo hydrolysis and 
its products of degradation are either metabolized by being included in the tricarboxylic 
acid cycle or eliminated by renal secretion.  
 
 
Fig. 3. Chemical structure of PCL. 
The authors modified the polymer with 2-isocyanatoethylmethacrylate (IEMA) to form a 
macromer that was crosslinked via UV irradiation using Irgacure® 2959 by CIBA as the 
photoinitiating agent. Results showed that after 60s of irradiation the curing of the 
polymer was complete and membranes were obtained. The resultant films were then 
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characterized by several techniques that included swelling evaluation, thermal 
characterization, surface energy determination, electronic microscopy, biodegradation in 
human plasma and haemocompatibility (haemolysis and thrombogenicity). In a global 
appreciation, it was concluded that the obtained membranes presented a porous 
morphology and that biodegradation occurred although in a slow rate (10% of weight loss 
after 6 weeks). Also, the material was haemocompatible (no significant value of 
haemolyisis was measured) and presented thrombogenic character (which would 
contribute to control wound bleeding). Finally, the adhesive was also able to promote 
efficient adhesion between the aminated substrates (gelatin was used as a model 
material), since during the binding strength tests, the gelatin pieces broke without 
compromising the glued section. The adhesive was posteriorly tested in vivo using Wistar 
rats, in two organs (skin and liver) and it proved to be efficient in keeping the glued 
surfaces together (even in moisture conditions) for the entire experimental protocol. After 
this period, the animals were euthanized and histological study of these organs was 
performed (hematoxylin & eosin coloration technique). No signs of necrosis or 
inflammation were detected in any of the target organs. Figure 4 presents a scheme 
summarizing the steps involved in this study. 
3.2 Drug delivery systems 
Drug delivery systems aim to control and sustain the distribution of drugs to attain 
optimal therapeutic efficiency. The earliest drug delivery systems were introduced in the 
1970s and were based on poly(lactic acid). Nowadays, polymers are still the most used 
materials in this field of research mainly because of their ease of processing and also 
because of the possibility of researchers to control both their physical and chemical 
properties. 
3.2.1 Ophthalmology 
Recently, significant advances have been made in optimizing the delivery of drugs to 
target tissues within the eye and in maintaining effective drug doses within those tissues 
(Geroski & Edelhauser, 2000). However, and despite all efforts, conventional ocular 
therapy for the treatment of acute and chronic diseases makes use of topical appliance of 
eye drops. This type of therapeutics represents nearly 90% of the marketed formulations. 
Still, this kind of appliance has a limited efficacy that is due to several factors, namely 
lacrimation, tear drainage and turnover, and the composition of the precorneal tear film 
itself. 
One of the major limiting factors for drug absorption from the lachrymal fluid into the 
anterior chamber, after eye drop administration, is the low permeability of the corneal 
epithelium that results in a very low (around 5%) drug absorption by the cornea. The 
corneal epithelium consists of approximately five to seven cell layers (Figure 5) which make 
it a strong barrier to drug permeation. 
The remaining amount of drug flows with tears through the upper and lower canonically 
into the nasolachrymal ducts and consequently may cause unwanted systemic side effects 
(Ali & Lehmussaari, 2006). The self-protective mechanisms of the eye, such as rapid tear 
turnover, limit the absorption of the instilled drug in the eye. In addition, application of 
ophthalmic drugs as drops results in rapid variation in drug delivery rates to the cornea that 
limits the efficacy of therapeutic systems. 
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Fig. 4. Summary of the development and characterization of a UV curable PCL based 
bioadhesive.  
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Fig. 5. Diagram showing the various layers of the corneal epithelium. 
In order to improve the patient compliance for delivering the medications there is the need 
for finding some new implantable devices which could deliver the drugs in a long-lasting 
controlled manner. Using this strategy, the drug loss associated with systemic absorption 
would be minimized, and the resident time of the drug in the tear film increased (Ludwig, 
2005). An alternative approach to optimize ophthalmic drug delivery is the adaptation of 
bioadhesive systems (Vasir et al., 2003), namely mucoadhesive ones, which have been 
proved to be successful in oral applications (Bernkop-Schnürch, 2005). 
Initially, intraocular implants aimed to achieve controlled and long lasting drug delivery for 
patients with glaucoma, proliferative vitroretinopathy, cytomegalovirus retinitis, 
endophtalmitis, and posterior capsule opacification. Nowadays, new ambitions rely on the 
development of new drug delivery systems namely therapeutic targeting of retinal 
degenerative diseases and angiogenic reactions which lead to blindness (Bourges et al., 2006). 
These systems are prepared using different kinds of biodegradable or non-biodegradable 
polymers and can present several shapes: sheet, pellet, disc, rod, or plug (Figure 6). 
 
 
Fig. 6. Routes of ocular drug delivery. (Adapted from Short, 2008). 
Among non-biodegradable implants, the best documented are based on polyvinyl alcohol 
(PVA)-ethylene vinyl acetate (EVA) (Okabe et al., 2003) and polysulfone (under the form of 
capillary fibers; Rahimy et al., 1994) Although both systems proved to efficiently control 
drug delivery for a long period of time, they present the disadvantage of being surgically 
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removed once the entire amount of drug has been released (Bourges et al., 2006). In order of 
overcoming this limitation biodegradable systems have been prepared based on several 
different polymers, namely: poly(lactic-co-glycolic acid) (Yasukawa et al., 2005); 
polycaprolactone (Shi et al., 2005); polyanhydrides (Leong et al., 1986) and poly(ortho esters) 
(Heller, 2005). 
In our research group, a starch-based polymer with urethane linkages to be used as a 
controlled drug delivery system for biomedical applications was developed (Vieira et al., 
2008). Hydroxyl groups present on starch were modified with 2-isocyanatoethyl 
methacrylate (IEMA) in order to obtain a polymer containing carbon–carbon double bonds. 
This modified starch was then used to prepare films by UV irradiation using Irgacure® 2959 
(CIBA) as the photoinitiator.  
The obtained films were characterized by several techniques and some parameters were 
evaluated. The swelling capacity in artificial lachrymal fluid (performed both at room 
temperature and physiological temperature), was determined and even though some 
hydroxyl groups of starch were modified, it was observed that polymeric matrix remained 
hydrophilic. The in vitro biodegradation in artificial lachrymal fluid supplemented with 
lysozyme was also studied for 6 weeks and it was verified that biodegradation of the 
samples remained almost constant during experimentation time. Scanning electronic 
microscopy (SEM) was used to characterize the morphology of the materials immediately 
after synthesis and after biodegradation and it was possible to visualize pore size increasing 
due to the degradation process. Since the main goal of this work was to develop a controlled 
drug delivery system for ophthalmic application, timolol maleate and sodium flurbiprofen 
were immobilized by adsorption inside the polymeric matrix and their in vitro release 
profiles were followed spectroscopically (for 10 days). As general conclusions, one can 
mention that it was possible to verify that the drugs’ incorporation into the polymer matrix 
was mainly controlled by the swelling behavior of the polymer, rather than the different 
characteristics of each tested drug. Also, drug release studies proved that incorporation of 
the each drug resulted in a different diffusional behavior. Timolol revealed to be a Case II 
diffusional anomalous process, whereas flurbiprofen diffusion presented a typical Fickian 
release pattern. However, the main driving force of the release pattern in both cases appears 
to be diffusion of the drugs from the polymeric matrices. Figure 7 presents a scheme 
summarizing the steps involved in this study. 
3.2.2 Responsive hydrogels for dermatologic applications 
Human skin is an easily accessible surface for drug delivery and covers a surface of 
approximately 2m2 in a young adult. Also, it receives about one-third of the blood 
circulating through the body. For these reasons, transdermal drug delivery (Figure 8) 
represents an attractive alternative to oral delivery of drugs as well as to hypodermic 
injection since is a non-invasive technique and can be self-administered. 
The first transdermal drug delivery system was approved by the FDA in 1979 and consisted 
in a patch with a 3 days release of scopolamine (an alkaloid used in the treatment of nausea 
and motion sickness). During following years, many systems were developed and some of 
them remain until now as real best-sellers (Prausnitz and Langer, 2008). Among them, 
nicotine patches are probably the more broadly used. Other systems available on the market 
include the ones containing: fentanyl (a synthetic narcotic analgesic), lidocaine (a local 
anesthetic) and hormones (either for contraception or hormone replacement). In fact, 
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transdermal patches are so largely used nowadays, that it is estimated that more than one 
billion are currently manufactured each year. 
 
 
Fig. 7. Summary of the development and characterization of a UV curable starch based drug 
delivery system.  
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Fig. 8. Scheme of a transdermal drug delivery system. 
Among the systems designed for drug release, the ones based on hydrogels are receiving 
most of the current attention. Hydrogels used for this purpose are usually prepared outside 
the organism and impregnated with drugs before placement of the system in the body. 
Several methods are available to achieve crosslinking of the matrices, namely UV 
photopolymerization and various chemical cross-linking techniques (Hoare and Kohane, 
2008). 
Hydrogels are materials that, when placed in aqueous medium absorb and retain large 
amounts of water without dissolving in the solution (Hennink and van Nostrum, 2002; Hatice 
Kaplan, 2005). In the polymeric structure of hydrogels, the hydrophilic parts of gels tend to be 
highly hydrated in the aqueous environment triggering the big water uptake that characterizes 
these structures (Coviello et al., 2007). Because of their properties, namely hydrophilicity and 
biocompatibility, hydrogels have been a subject of interest in different areas especially in the 
preparation of drug delivery systems (DDS) (Hoffman, 2002; Ulbrich, 1995).  
Both natural and synthetic polymers can be used to prepare hydrogels. Natural-based 
hydrogels lack mechanical strength and may contain pathogens that induce immune or 
inflammatory host responses. However, they simultaneously present some advantages such 
as their biodegradability, biocompatibility and biologically recognizable moieties that are 
compatible with cellular activities Synthetic hydrogels, on the other hand, do not possess 
these inherent bioactive properties and are often modified in order to improve their 
bioactivity (Bajpai et al., 2008).  
Although the variety of hydrogels already used as DDS, a great interest in this field of 
research still exists mainly in the development of gels that present a phase transition that 
responds to changes in external conditions. The most important systems from biomedical 
point of view are those sensitive to temperature and/or pH of the surroundings. These 
materials are known as “stimuli-responsive” or “smart” gels and can undergo abrupt 
volume changes in response to small changes in environmental parameters. Their ability to 
swell or deswell according to external conditions, leads to a drug release profile that varies 
with the same specific parameters (Figure 9).  
Among stimuli responsive hydrogels, we will be focusing on the ones sensitive to 
temperature. These materials are prepared using polymers in carefully chosen in order to 
achieve a delicate balance between hydrophilic and hydrophobic groups. The most 
extensively studied temperature-sensitive polymer is poly(N-isopropylacrylamide) or 
PNIPAAm which consists on a non-biodegradable polymer (Figure 10).  
PNIPAAm shows a lower critical solution temperature (LCST) at approximately 32ºC which 
means that is soluble in water below this temperature but precipitates rapidly when 
temperature is raised above 32ºC. This means that crosslinked gels prepared using these 
polymers suffer an abrupt change in their volume when temperature value varies above or 
below the LCST (Satish et al., 2006). In fact, these materials expand and swell when cooled 
below the LCST, and shrink and collapse when heated above the LCST. As a consequence, 
drug release profile undergoes the same variations patterns. 
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Fig. 9. Schematic representation of the on–off release from an intelligent stimuli-responsive 
hydrogel designed for drug release. 
 
H2C C
H
C O
NH
CH
H3C CH3
n
 
Fig. 10. Chemical structure of PNIPAAm. 
Several works have been reported using crosslinked gels based on PNIPAAm starting with 
Tanaka (1981). Later, this same polymer was used to develop materials to be applied as 
biomaterials (Dong and Hoffman, 1990). These authors recognized its potential to entrap 
enzymes or cells and regulate their activity by manipulating swelling/deswelling of the 
hydrogel (Dong and Hoffman, 1986; 1987). They also studied the possibility or delivering 
drugs or removing toxins by such hydrogels when controlling external stimuli (Dong and 
Hoffman, 1991; Park and Hoffman, 1992). Since then, PNIPAAm hydrogels have been 
prepared under several forms and for various purposes. Vernon and co-workers 
synthesized gels with entrapped cells to be used as artificial organs (Vernon et al., 2000). A 
few years later, Dubé and co-workers (Dubé et al., 2002) prepared drug carriers for tumoral 
cells by synthesizing folate-PNIPAAm conjugates that were fluorescently labeled. They 
evaluated the targeting specificity of this complex by measuring its cellular uptake. They 
also conducted direct competition experiments with free folate and demonstrated that the 
PNIPAAm-folate conjugates effectively target the cells even at folate concentration above 
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normal serum levels. PNIPAAm nanoparticles have also been prepared and their potential 
applications in biotechnology and in medicine evaluated. Koňák and colleagues (2007) 
prepared thermoresponsive nanoparticles by heating PNIPAAm solutions with low 
surfactant additions above the LCST. More recently the preparation of a poly(N-
isopropylacrylamide)-co-poly(ethylene glycol) (PNIPAAm–PEG) injectable scaffold 
platform for the repair of spinal cord injury (SCI) was reported (Comolli et al., 2009). The 
authors stated that this scaffold allows cell attachment, provides mechanical support and 
allows a sustained release of neurotrophins (growth factors that induce the survival, 
development, and function of neurons). 
Another approach on the synthesis of crosslinkable hydrogels is grafting of PNIPAAm 
linear chains onto natural polymers (Hoare and Kohane, 2008). As an example, 
temperature-sensitive injectable gels were prepared by grafting amino-terminated semi-
telechelic PNIPAAm onto hyaluronic acid (HA) backbones (Ha et al., 2006). Riboflavin 
was entrapped in the resulting gel and in vitro tests results showed a more sustained 
release behavior when the grafting yield of PNIPAAm onto the HA backbone was 
increased. Another example is the work performed by Bae and co-workers (2006). These 
authors prepared two types of injectable systems using thermosensitive chitosan (chitosan 
grafted with PNIPAAm): a hydrogel and microparticles-embedded hydrogel. Both 
systems were developed as drug carriers for controlled release of 5-fluorouracil (5-FU). 
The results from this study showed that 5-FU release profile from microparticles-
embedded hydrogel reduced the burst effect from the beginning of each initial stage. 
Therefore, the authors suggest that this combined system could be used as an injectable 
drug carrier for local drug delivery. 
PNIPAAm networks interpenetrated in alginate–Ca2+ networks were synthesized and the 
release of bovine serum albumin (BSA) from the hydrogels was evaluated by Moura and co-
workers (2008). The authors concluded that the amount and rate of BSA release could be 
tailored by the tuning up of the PNIPAAm and/or alginate quantity in the hydrogel and by 
the control of temperature. 
Recently a combination of biodegradable microspheres with a PNIPAAm hydrogel was 
prepared by Yang and colleagues (2011). They studied the release of BSA from the system 
and concluded that controlled release of BSA encapsulated in the microspheres embebbed 
in PNIPAAm scaffold was better controlled than when encapsulated in the hydrogel 
alone. 
Temperature-sensitive hydrogels can also be useful for topical delivery of drugs to skin or 
mucous membranes such as the nose or the eyes. Although the temperature of such surfaces 
is slightly below 37ºC, its value is still above ambient temperature which means that it 
would be possible to deliver a drug through a thermo-responsive polymer. 
One example of such application is the work developed by Almeida and co-workers (2010) 
at our laboratory during which, graft polymer hydrogels based on dextran and N-
isopropylacrylamide (NIPAAm) were prepared and characterized. For that purpose, 
dextran was firstly modified in order to incorporate carbon-carbon double bonds and then 
NIPAAm was added to the modified polymer. The resultant material (dextran-grafted-
PNIPAAm) was obtained by crosslinking using UV irradiation in the presence of the 
photoinitiating agent Irgacure® 2959 by CIBA. The drug Ondansetron® (an antiemetic used 
to treat nausea and vomiting, frequently following chemotherapy, Figure 11) was entrapped 
in the final system and its release profile was determined at 25 and 37ºC. The authors 
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concluded that controlled release of the drug occurred for at least one week and that 
temperature influenced drug release pattern. 
N
O
N
N
H3C
CH3  
Fig. 11. Chemical structure of Ondansetron®. 
These results are extremely important as they show that these systems can be adjusted to 
have different transition temperatures according to the applications needed giving them a 
wide range of use. 
4. Conclusions 
Photocrosslinked polymers may be very useful for biomedical applications.  
The use of photopolymerization is advantageous in comparison with other conventional 
crosslinking methods, since we can obtain biomaterials in situ and in a minimally invasive 
manner.  
The photopolymerizable polymers based either in natural (starch, chitosan and dextran) or 
synthetic polymers (polycaprolactone), were used for the development of biomaterials, 
mainly hydrogels. 
These materials were applied in the development of bioadhesives, drug delivery systems for 
ophthalmology and wound dressings. 
The results of our research indicate that the systems are suitable for medical applications 
and make feasible innovative strategies for photocrosslinked polymers in clinical use.  
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